Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Karyopharm Therapeut
(NQ:
KPTI
)
0.8335
+0.0463 (+5.88%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Karyopharm Therapeut
< Previous
1
2
3
4
5
6
Next >
Expert Ratings for Karyopharm Therapeutics
September 09, 2022
Analysts have provided the following ratings for Karyopharm Therapeutics (NASDAQ:KPTI) within the last quarter:
Via
Benzinga
Where Karyopharm Therapeutics Stands With Analysts
September 09, 2022
Karyopharm Therapeutics (NASDAQ:KPTI) has observed the following analyst ratings within the last quarter:
Via
Benzinga
HashiCorp, Pagerduty, Lululemon And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
September 02, 2022
Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) surged 13.5% to $19.25 in pre-market trading. A consortium led by Hollysys Automation’s management is looking to take the US-listed company private...
Via
Benzinga
Why Pagerduty Is Trading Higher By 9%; Here Are 28 Stocks Moving Premarket
September 02, 2022
Gainers
Via
Benzinga
Karyopharm Therapeutics Earnings Perspective: Return On Capital Employed
August 18, 2022
Via
Benzinga
Analyst Ratings for Karyopharm Therapeutics
May 05, 2022
Analysts have provided the following ratings for Karyopharm Therapeutics (NASDAQ:KPTI) within the last quarter:
Via
Benzinga
Recap: Karyopharm Therapeutics Q1 Earnings
May 05, 2022
Karyopharm Therapeutics (NASDAQ:KPTI) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Karyopharm Therapeutics: Q2 Earnings Insights
August 04, 2022
Karyopharm Therapeutics (NASDAQ:KPTI) reported its Q2 earnings results on Thursday, August 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
August 02, 2022
Tuesday's session saw 63 companies set new 52-week lows.
Via
Benzinga
Daily Biotech Pulse: Liver Disease-Focused Gene Therapy Pact, Assembly Bio Stops HBV Infection Trial, X4 Pharma Looks For Partners
July 21, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Karyopharm Shares Soar Following European Commission's Marketing Authorisation For Multiple Myeloma Candidate
July 21, 2022
The European Commission (EC) has granted Marketing Authorisation for Karyopharm Therapeutics’ (NASDAQ: KPTI) lead candidate NEXPOVIO (selinexor) in combination with once-weekly bortezomib (Velcade) and...
Via
Benzinga
Recap of Wednesday's Biotech Catalysts - End of The Day Summary
July 20, 2022
Via
Benzinga
Karyopharm Shares Soar On FDA Fast Track Status, EU Orphan Medicinal Product Status To Preleukemia Candidate
July 20, 2022
The U.S. Food and Drug Administration (FDA) has granted fast track designation to Karyopharm Therapeutics’ (NASDAQ: KPTI) lead asset Eltanexor as monotherapy for the treatment of patients with relapsed...
Via
Benzinga
The Daily Biotech Pulse: Roche's Alzheimer's Drug Fails, Advisors Back Pfizer, Moderna Shots For Youngest Kids, Valneva Settles COVID-19 Pact With UK
June 16, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Karyopharm Therapeutics' Shares Slide After Biogen Terminates 2018 Asset Purchase Agreement
June 15, 2022
Via
Benzinga
Looking Into Karyopharm Therapeutics's Return On Capital Employed
May 27, 2022
Karyopharm Therapeutics (NASDAQ:KPTI) brought in sales totaling $47.67 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 206.92%, resulting in a loss of $41.40...
Via
Benzinga
The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study
May 05, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Karyopharm Therapeutics Earnings Preview
May 04, 2022
Karyopharm Therapeutics (NASDAQ:KPTI) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
What 5 Analyst Ratings Have To Say About Karyopharm Therapeutics
March 18, 2022
Over the past 3 months, 5 analysts have published their opinion on Karyopharm Therapeutics (NASDAQ:KPTI) stock. These analysts are typically employed by large Wall Street banks...
Via
Benzinga
The Daily Biotech Pulse: AbbVie's Rinvoq Gets Label Expansion, AstraZeneca COVID Antibody Cocktail Authorized By UK Regulator, Stealth Touts Positive Data
March 17, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Mid-Afternoon Market Update: Dow Gains 2%; SAB Biotherapeutics Shares Slide
March 02, 2022
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining 2% on Wednesday. The Dow traded up 2.07% to 33,983.50 while the NASDAQ rose 1.77% to 13,771.67. The...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 02, 2022
Gainers Trevi Therapeutics (NASDAQ:TRVI) shares rose 46.6% to $1.28 during Wednesday's regular session. As of 12:30 EST, Trevi Therapeutics's stock is trading at a...
Via
Benzinga
68 Biggest Movers From Yesterday
March 03, 2022
Gainers ECMOHO Limited (NASDAQ: MOHO) climbed 56.7% to close at $0.3650 on Wednesday after jumping 10% on Tuesday. Imperial Petroleum Inc. (NASDAQ: IMPP) shares jumped 39.2% to...
Via
Benzinga
41 Stocks Moving In Wednesday's Mid-Day Session
March 02, 2022
Gainers ECMOHO Limited (NASDAQ: MOHO) jumped 67% to $0.3890 after jumping 10% on Tuesday. Nordstrom, Inc. (NYSE: JWN) shares jumped 38.7% to $27.11 after the company reported...
Via
Benzinga
Mid-Day Market Update: Nasdaq Surges 150 Points; US Crude Oil Inventories Fall By 2.6M Barrels
March 02, 2022
U.S. stocks extended gains midway through trading, with the Nasdaq index jumping 150 points on Wednesday. The Dow traded up 1.71% to 33,865.43 while the NASDAQ rose 1.11% to 13,...
Via
Benzinga
Mid-Morning Market Update: U.S. Stocks Mixed; Dollar Tree Reports Mixed Q4 Results
March 02, 2022
U.S. stocks opened mixed this morning, with the Dow Jones adding more than 200 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.66% to 33,513.04...
Via
Benzinga
Where Karyopharm Therapeutics Stands With Analysts
March 02, 2022
Karyopharm Therapeutics (NASDAQ:KPTI) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
March 02, 2022
Gainers IsoPlexis (NASDAQ:ISO) shares moved upwards by 22.8% to $5.5 during Wednesday's pre-market session. The company's market cap stands at $214.2 million. The...
Via
Benzinga
The Daily Biotech Pulse: Karyopharm Flags Delay In Selinexor Label Expansion, Finch, Celyad Hit With Clinical Holds, Adagene Strikes R&D Collaboration With Sanofi
March 02, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Karyopharm Says FDA Mandates Additional Study For Expanding Selinexor Label...
Via
Benzinga
Why Are Karyopharm Shares Trading Lower Today
March 02, 2022
Karyopharm Therapeutics Inc (NASDAQ: KPTI) stock plunged after an update on its supplemental New Drug Application submission based on the Phase 3 SIENDO study data...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.